Assessment of anticoagulant effect of evening primrose oil

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 4, 2009, Pages 355-359

  Riaz, Azra ^a   Khan, Rafeeq Alam ^a   Ahmed, Shahida Parveen ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Activated partial thromboplastin time; Evening primrose oil; Fibrinogen time; Prothrombin time; Thrombin time

Indexed keywords

FIBRINOGEN; PRIMROSE OIL; WARFARIN;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG EFFECT; MORBIDITY; MORTALITY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RABBIT; RECOMMENDED DRUG DOSE; RISK REDUCTION; THROMBIN TIME; THROMBOCYTE COUNT;

ANIMALS; ANTICOAGULANTS; FEMALE; FIBRINOGEN; GAMMA-LINOLENIC ACID; LINOLEIC ACIDS; MALE; PARTIAL THROMBOPLASTIN TIME; PLANT OILS; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PROTHROMBIN TIME; RABBITS; THROMBIN TIME; WARFARIN;

EID: 70349775733     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Alcaraz MJ and Jimenez MJ (1989). Anti-inflammatory compound from sideritis javalambrensis n-hexane extract. Journal of Natural Products, 52: 1088-1091.
2. Alison MJ, Keegan A, Cotter MA and Cameron NE (2002). Effects of diabetes and evening primrose oil treatment on responses of aorta, corpus cavernosum and mesenteric vasculature in rats. Life Sciences, 71: 1863-1877. (Pubitemid 34880234)
3. Allford SL and Machin SJ (2007). Haemostasis. Surgery, 25: 241-244.
4. Balasinska B (1998). Hypocholesterolemic effect of dietary evening primrose oil (Oenothera paradoxa) cake extract in rats. Food Chemistry, 63: 453-459. (Pubitemid 29034613)
5. Brummel KE, Butenas S and Mann KG (1999). An integrated study of Fibrinogen during Blood Coagulation. J. Biological Chemistry, 274: 22862-22870. (Pubitemid 29379337)
6. Brummel KE, Paradis SG, Butenas S and Mann KG (2002). Thrombin functions during tissue factor-induced blood coagulation. Blood, 100: 148-152. (Pubitemid 35177440)
7. Burns MM (2000). Alternative medicine: Herbal preparation. Clin. Ped. Emerg. Med., 1: 186-190.
8. Cartledge JJ, Eardley Y and Morrison JFB (2000). Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin. British Journal of Urology International, 85: 734-735.
9. Chan Kung-chi, Yin Mei-chin and Chao Wan-ju (2007). Effect of diallyl trisulfide-rich garlic oil on blood coagulation and plasma activity of anticoagulation factors in rats. Food and Chemical Toxicology, 45: 502-507.
10. Chandler WL and Velan T (2003). Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Hemostasis, thrombosis and vascular biology. Blood, 101: 4355-4362.
11. Colman RW (2006). Are hemostasis and thrombosis two sides of the same coin? J. Exp. M., 203: 493-495.
12. Cruz JPDL, Romero MM, Carmona JA and Villalobos MA (1997). Effect of evening primrose oil on platelet aggregation in rabbits fed an atherogenic diet. Thrombosis Research, 87: 141-149.
13. Di Cera E (2008). Thrombin. Review. Molecular Aspects of Medicine, 29: 203-254.
14. Dines KC, Cotter MA and Cameron NE (1995). Comparison of the effect of Evening primrose oil and triglycerides containing gamma linolenic acid on nerve conduction and blood flow in diabetic rats. J. Pharmaccol. Exp. Ther., 273: 49-55.
15. Dirks J, Aswegen CHV and Plessis DJ (1998). Cytokine levels affected by gamma-linolenic Acid. Prostaglandins, Leukotrienes and Essential Fatty Acids, 59: 273-277. (Pubitemid 28523777)
16. Fang C, Jiang Z and Tomlinson DR (1997). Expression of constitutive cyclooxygenases (COX.l) in rats with streptozotocin-induced diabetes; effects of treatment with evening primrose oil or an aldose reductase inhibitor on COX-1 mRNA levels. Prostaglandins, Leukotrienes and Essential Fatty Acid, 56: 157-163. (Pubitemid 27076247)
17. Fielsend AF and Morison JIL (2000). Climatic conditions during seed growth significantly influence oil content and quality in winter and spring evening primrose crops (oenothera spp.). Industrial Crops and Products, 12: 137-147.
18. Ford I, Cotter MA, Cameron NE and Greaves M (2001). The effects of treatment with α-lipoic acid or evening primrose oil on vascular haemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism, 50: 868-875.
19. Gage BF, Fihn SD and White RH (2000). Management and dosing of warfarin therapy. Am. J. Med., 109: 481-488.
20. Gailani D and Renne T (2007). Intrinsic pathway of coagulation and arterial thrombosis. Arteriosclerosis Thrombosis and Vascular Biology, 27: 2507-2513. (Pubitemid 350158899)
21. Hamer M and Emmanual S (2008). The accumulative effects of modifiable risk factors on inflammation and Haemostasis. Brain, Behavior, and Immunity, 22: 1041-1043.
22. Hamilton JR (2008). Protease-activated receptors as targets for antiplatelet therapy. Blood Reviews, 06: 1-5.
23. Hassig A, Liang WX and Stampfli K (2000). Bronchial asthma: information on phytotherapy with essential fatty acids. Medical Hypotheses, 54: 72-74.
24. Kamali F, Edwards C, Wood P, Wynne HA and Kesteven P (2001). Temporal variation in plasma vitamin K and lipid concentration and clotting factor activity in humans. American Journal of Hematology, 68: 159-163. (Pubitemid 32983203)
25. Krupiczojc MA, Scotton CJ and Chambers RC (2008). Coagulation signaling following tissue injury: Focus on the role of factor Xa, The International Journal of Biochemistry & Cell Biology, 40: 1228-1237.
26. Kuruvilla R, Peterson RG, Kincaid JC and Eichberg J (1998). Evening primrose oil treatment corrects reduced conduction velocity but not depletion of arachidonic acid in nerve from streptozotocin-induced diabetic rats. Prostaglandins, Leukotrienes and Essential Fatty Acids, 59: 195-202. (Pubitemid 28505112)
27. Lane DA, Philippou H and Huntington JA (2005). Directing Thrombin. Blood, 06: 2605-2612.
28. Matsuo N, Osada K, Kodama T, Lim BO, Nakao A, Yamada K and Sugano M (1996). Effects of γ-1inolenic acid and its positional isomer pinolenic acid on immune parameters of Brown-Norway rats, Prostaglandins, Leukotrienes and Essential Fatty Acids. 55: 223-229. (Pubitemid 26384199)
29. Miller GJ (2005). Dietary fatty acids and the haemostatic system. Review: Atherosclerosis, 179: 213-222.
30. Mitropoulos KA, Esnouf MP and Meade TW (1987). Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Atherosclerosis, 63: 43-52.
31. Orfao SC, Jank G, Mottaghy K, Walcher S and Zerz E (2008). Qualitative properties and stabilizability of a model for blood thrombin formation. Journal of Mathematical Analysis and Applications, 346: 218-226.
32. Peschel W, Dieckmann W, Sonnenschein M and Plescher A (2007). High antioxidant potential of pressing residues from evening primrose in comparison to other oilseed cakes and plant antioxidants. Industrial Crops and Products, 25: 44-54. (Pubitemid 46001570)
33. Peterson LD, Thies F and Calder PC (1999). Dosedependent effects of dietary γ-linolenic acid on rat spleen lymphocyte functions. Prostaglandins, Leukotrienes and Essential Fatty Acids, 61: 19-24. (Pubitemid 29401608)
34. Puri BK (2004). The clinical advantages of cold-pressed non-raffinated evening primrose oil over refined preparations. Medical Hypotheses, 62: 116-118.
35. Rallidis LS, Georgios P, Papaioannou ML, Liakos GK, Panagiotakos DB, Anastasiadis G and Zampelas A (2004). The effect of diet enriched with α-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients. Atherosclerosis, 174: 127-132. (Pubitemid 38595450)
36. st International Standard for Factor XIII, Plasma (02/206). Final report and recommendations. World Health Organization. Expert Committee on Biological Standardarization Geneva, 15 to 19 November 2004. WHO ORGANISATION MONDIALE DE LA SANTE.
37. Renaud S, Gregor LM, Morazain R, Thevenon C, Benoit C, Dumont E and Mendy F (1982). Comparitive beneficial effects on platelets functions and atherosclerosis of dietary linoleic and γ-linolenic acids in the rabbit, Atherosclerosi, 45: 43-51. (Pubitemid 13237669)
38. Senanayake Namal SPJ and Shahidi F (2004). Incorporation of docosahexaenoic acid (DHA) into evening primrose oil (Oenothera biennis L.) oil via lipase-catalyzed transesterification. Food Chemistry, 85: 489-496.
39. Setty AR and Sigal LH (2005). Herbal medications commonly used in the practice of rheumatology: Mechanisms of action, efficacy, and side effects. Seminars in Arthritis and Rheumatism, 34: 773-784.
40. Shearer MJ (2009). Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Reviews, 23(2): 49-59.
41. Wolberg AS (2007). Thrombin generation and fibrin clot structure. Blood Reviews, 21: 131-142. (Pubitemid 46541695)
42. Yuan S, Ferrell C and Chandler WL (2007). Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thrombosis Research, 120: 29-37. (Pubitemid 46601569)
43. Zacchigna M, Luca GD, Cateni F and Maurich V (2004). Improvement of warfarin bio pharmaceutics by conjugation with poly (ethylene glycol). European Journal of Pharmaceutical Sciences, 23: 379-384. (Pubitemid 39573389)